These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34928191)

  • 1. A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study.
    Zhao S; Peng Z; Wang MH
    Pathog Glob Health; 2022 May; 116(3):137-139. PubMed ID: 34928191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa.
    Liu Y; Yu Y; Zhao Y; He D
    Int J Infect Dis; 2022 Jul; 120():146-149. PubMed ID: 35462038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.
    Yu Y; Yu Y; Zhao S; He D
    Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
    Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
    Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of non-pharmaceutical interventions on the first COVID-19 epidemic wave in South Africa.
    Mabuka T; Ncube N; Ross M; Silaji A; Macharia W; Ndemera T; Lemeke T
    BMC Public Health; 2023 Aug; 23(1):1492. PubMed ID: 37542267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).
    Yang W; Shaman JL
    Elife; 2022 Aug; 11():. PubMed ID: 35943138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SARS-CoV-2 variants: the pandemics within the pandemic.
    Boehm E; Kronig I; Neher RA; Eckerle I; Vetter P; Kaiser L;
    Clin Microbiol Infect; 2021 Aug; 27(8):1109-1117. PubMed ID: 34015535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of universal health coverage and global health security nexus and interplay on SARS-CoV-2 infection and case-fatality rates in Africa : a structural equation modeling approach.
    Biadgilign S; Hailu A; Gebremichael B; Letebo M; Berhanesilassie E; Shumetie A
    Global Health; 2023 Jul; 19(1):46. PubMed ID: 37415196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021.
    Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Gómez-Olivé FX; Dawood FS; Mkhencele T; ; Tempia S
    BMC Infect Dis; 2024 Mar; 24(1):336. PubMed ID: 38515050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study.
    Arendse T; Cowper B; Cohen C; Masha M; Tempia S; Legodu C; Singh S; Ratau T; Geffen L; Heymans A; Coetzer D; Blumberg L; Jassat W
    BMC Public Health; 2022 May; 22(1):1035. PubMed ID: 35606732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
    Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
    Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa.
    Reichert E; Schaeffer B; Gantt S; Rumpler E; Govender N; Welch R; Shonhiwa AM; Iwu CD; Lamola TM; Moema-Matiea I; Muganhiri D; Hanage W; Santillana M; Jassat W; Cohen C; Swerdlow D
    Lancet Microbe; 2022 Oct; 3(10):e753-e761. PubMed ID: 36057266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Country differences in transmissibility, age distribution and case-fatality of SARS-CoV-2: a global ecological analysis.
    Favas C; Jarrett P; Ratnayake R; Watson OJ; Checchi F
    Int J Infect Dis; 2022 Jan; 114():210-218. PubMed ID: 34749011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods.
    Al Hasan SM; Saulam J; Mikami F; Kanda K; Yokoi H; Hirao T
    J Infect Public Health; 2022 Jul; 15(7):726-733. PubMed ID: 35687982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of transmissibility of SARS-CoV-2 variants of concern.
    Manathunga SS; Abeyagunawardena IA; Dharmaratne SD
    Virol J; 2023 Apr; 20(1):59. PubMed ID: 37009864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
    Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
    Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproduction Numbers of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants: A Systematic Review and Meta-analysis.
    Du Z; Liu C; Wang C; Xu L; Xu M; Wang L; Bai Y; Xu X; Lau EHY; Wu P; Cowling BJ
    Clin Infect Dis; 2022 Aug; 75(1):e293-e295. PubMed ID: 35171991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.